Spravato

It’s difficult to live a fulfilling life when depression is blocking your path. And although there are a range of choices of treatment available, they won’t be the answer in every situation. If you’ve explored various possibilities and still agonize over overwhelming depression, our team may be able to help. Our accredited therapists are experienced in managing treatment-resistant depression with a medication called SPRAVATO®.

What is SPRAVATO?

Spravato (esketamine) CIII is taken as a nasal spray and used to combat treatment-resistant depression (TRD). When you have sought help from a minimum of two antidepressant medications with minimal relief of depressive symptoms, using SPRAVATO could be beneficial. Many individuals finally gain a reprieve from their depression when taking SPRAVATO alongside an antidepressant. Numerous individuals who take SPRAVATO alongside an oral antidepressant experience lowered depression symptoms in four weeks. Clinical studies have shown the effects of SPRAVATO can be experienced within one day of the initial dose.

SPRAVATO is a derivative of ketamine. It is the lone form of ketamine in the US that is authorized for the treatment of depression. It stimulates certain brain neurotransmitters and helps them transmit messages more effectively to govern mood and decrease negative symptoms of depression.

Interested in learning more? Inquire below and our team will be happy to answer any questions you may have.